Gaps in Drugs Pipelines Spark a Flurry of Takeover Activity
Thursday, June 11, 2015
Source: Financial Times
The pharmaceuticals sector has been gripped by a mergers and acquisitions frenzy for the best part of two years, with some of the biggest names in the industry fighting over hot new drugs. Last year was a record for dealmaking in the sector and 2015 is also off to a strong start, with healthcare transactions worth $193.9bn announced since the beginning of January, according to Thomson Reuters.